CONTACT US

CONTACT US

CUSTOMER SERVICE

For ordering, billing, or finding your local sales representative, call 1.800.367.5737 or email
PRMOrder@allergan.com

ONLINE ORDERING

Click here: Allergan Direct

CLINICAL AND MEDICAL ASSISTANCE

Call 1.800.678.1605 or visit our
Medical Information website

REIMBURSEMENT SUPPORT

Call 1.888.543.3656 or email
AllerganPRM@thepinnaclehealthgroup.com

AlloDermTM Guarantee Program

The AlloDermTM Guarantee Program offers facility customers a replacement of any piece of AlloDermTM RTM that is explanted, subject to the program terms and conditions.

 AlloDerm™ RTM Guarantee AlloDerm™ RTM Guarantee AlloDerm™ RTM Guarantee

To be eligible for the guarantee, facilities must comply with all terms and conditions. For more information, contact your local Allergan Aesthetics representative today, or call Allergan Aesthetics Customer Service at 1.800.367.5737.

Download to learn more about the AlloDermTM RTM Guarantee.

Terms and Conditions

The AlloDermTM RTM Guarantee Program applies to all pieces of AlloDermTM RTM that are explanted, provided that the product has been used:
  • As intended by appropriately qualified and licensed surgeons
  • In accordance with the current AlloDermTM RTM Instructions for Use, found at www.allergan.com/AlloDermIFU
All AlloDermTM RTM replacement requests are subject to the Allergan Aesthetics review process. The AlloDermTM RTM Guarantee Program is available to all facility customers. No separate contract is required to take advantage of the program. If a facility receives a replacement piece of AlloDermTM RTM at no charge from Allergan Aesthetics, the facility will not seek reimbursement for the product from the patient or any government or private healthcare plans.

Reimbursement for AlloDermTM RTM

Reimbursement Hotline

The Reimbursement Hotline is our commitment to surgeons and facilities in their use of AlloDermTM RTM.


Our third-party team of credentialed professional medical coders is ready to assist you with your reimbursement needs, including*:
  • Coding and payment
  • Insurance coverage and documentation
  • Case management for benefit verification and prior authorizations (PAs)
  • Appeals support for denied PAs and/or claims
Monday to Friday 8:30 AM – 6:00 PM ET (closed on major observed holidays)
1.888.543.3656
1.877.499.2986

Providing physicians, hospitals, ambulatory surgical centers, and patients with comprehensive support

Reimbursement support includes:

Appeals assistance

Providing personalized appeals support for denied patient claims, including peer-to-peer reviews.

Coverage and
payment assistance

Conducting benefit verifications and confirming overall benefit structure for patient.

Education

Educating on correct coding, insurance coverage, policy guidelines, payment methodologies, required documentation, and payer regulations.

Prior authorization

Assisting with predetermination/
precertification process, including checking PA requirements and documentation needs, as well as appeals of denied PAs.

Processing support

Reviewing claims to assist with correct coding guidelines, billing options, and coverage in support of accurate claims processing, including support with irregular denials and inconsistent payment.

Regional Reimbursement Support Team

Our regional team members are available to provide tailored reimbursement support for your use of AlloDerm™ RTM.

Your reimbursement representative can assist your office with:

Economics/value proposition

Coding (physician, facility)

Understanding coverage

Reimbursement

Health policy (commercial, government)

Healthcare reform

Medical Support Team

If you have any medically related product inquiries, please call us at 1.800.678.1605, option 2, or visit https://www.abbviemedinfo.com/ for help from our medical support team. Based on your request, it will be triaged by one of the following team members:

Medical Information

Our Medical Information department serves to communicate information about our products by providing relevant journal articles, product literature, labeling information, and other relevant documentation.

Medical Affairs

Talk LIVE with a medical and scientific professional who serves as a scientific information resource to provide scientific and clinical data relating to the use of Allergan Aesthetics products, with the goal of optimizing patient care and treatment outcomes.

Regenerative Medicine Return Goods Policy

Click for Return Goods Policy

Downloadable materials

Our downloadable Safety and Quality brochure provides important information on donor screening, proprietary processing, and quality testing measures, as well as the final tissue characteristics for each piece of AlloDermTM RTM.

AlloDermTM RTM Safety and Quality Brochure

Learn more about our program that offers facility customers a replacement of any piece of AlloDermTM RTM that is explanted, subject to terms and conditions.

AlloDermTM RTM Guarantee Brochure

AlloDermTM RTM publications

Choose a topic below for a relevant selection of recent articles, or access a full bibliography of publications on PubMed.

Scientific articles

Host response to human acellular dermal matrix transplantation in a primate model of abdominal wall repair

Xu H, Wan H, Sandor M, et al. Tissue Eng Part A. 2008;14(12):2009-2019.

Extracellular wound matrices: a novel regenerative tissue matrix (RTM) technology for connective tissue reconstruction

Harper JR, McQuillan DJ. Wounds. 2007;19(6):163-168.

Human monocyte activation by biologic and biodegradable meshes in vitro

Orenstein SB, Qiao Y, Kaur M, Klueh U, Kreutzer DL, Novitsky YW. Surg Endosc. 2010;24(4):805-811.

*Correlation of these results, based on animal studies, to results in humans has not been established.

Head and neck procedures

For specific article inquiries, please visit the Medical Information website or call 1.800.678.1605.

Human acellular dermal matrix grafts for rhinoplasty

Sherris DA, Oriel BS. Aesthet Surg J. 2011;31(7 suppl):95S-100S.

AlloDerm for dorsal nasal irregularities

Jackson IT, Yavuzer R. Plast Reconstr Surg. 2001;107(2):553-558.

Cleft palate fistula closure utilizing acellular dermal matrix

Emodi O, Ginini JG, van Aalst JA, et al. Plast Reconstr Surg Glob Open. 2018;6(3):e1682. doi:10.1097/GOX.0000000000001682

Use of AlloDerm in the neurotologic setting

Weber PC, Lambert PR, Cunningham CD III, Richardson MS, Genao RB. Am J Otolaryngol. 2002;23(3):148-152.
ALLODERM SELECTTM REGENERATIVE TISSUE MATRIX INDICATIONS AND IMPORTANT SAFETY INFORMATION  

ALLODERM SELECTTM REGENERATIVE TISSUE MATRIX
INDICATIONS AND IMPORTANT SAFETY INFORMATION

INDICATIONS

ALLODERM SELECTTM Regenerative Tissue Matrix (ALLODERM SELECTTM RTM refers to both ALLODERM SELECTTM RTM and ALLODERM SELECT RESTORETM RTM products) is intended to be used for repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument. This product is intended for single patient one-time use only. ALLODERM SELECTTM RTM is not indicated for use as a dural substitute or intended for use in veterinary applications.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

ALLODERM SELECTDTM RTM should not be used in patients with a known sensitivity to any of the antibiotics listed on the package and/or Polysorbate 20.

WARNINGS

Processing of the tissue, laboratory testing, and careful donor screening minimize the risk of the donor tissue transmitting disease to the recipient patient. As with any processed donor tissue, ALLODERM SELECTTM RTM is not guaranteed to be free of all pathogens. No long-term studies have been conducted to evaluate the carcinogenic or mutagenic potential or reproductive impact of the clinical application of ALLODERM SELECTTM RTM.

DO NOT re-sterilize ALLODERM SELECTTM RTM. DO NOT reuse once the tissue graft has been removed from the packaging and/or is in contact with a patient. Discard all open and unused portions of the product in accordance with standard medical practice and institutional protocols for disposal of human tissue. Once a package or container seal has been compromised, the tissue shall be either transplanted, if appropriate, or otherwise discarded. DO NOT use if the foil pouch is opened or damaged. DO NOT use if the seal is broken or compromised. DO NOT use if the temperature monitoring device does not display “OK.” DO NOT use after the expiration date noted on the label. Transfer ALLODERM SELECTTM RTM from the foil pouch aseptically. DO NOT place the foil pouch in the sterile field.

PRECAUTIONS

Poor general medical condition or any pathology that would limit the blood supply and compromise healing should be considered when selecting patients for implanting ALLODERM SELECTTM RTM as such conditions may compromise successful clinical outcome. Whenever clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic anti-infective measures should be taken.

ALLODERM SELECTTM RTM has a distinct basement membrane (upper) and dermal surface (lower). When applied as an implant, it is recommended that the dermal side be placed against the most vascular tissue. Soak the tissue for a minimum of 2 minutes using a sterile basin and room temperature sterile saline or room temperature sterile lactated Ringer’s solution to cover the tissue. If any hair is visible, remove using aseptic technique before implantation.

ALLODERM SELECTTM RTM should be hydrated and moist when the package is opened. DO NOT use if this product is dry. Use of this product is limited to specific health professionals (e.g., physicians, dentists, and/or podiatrists). Certain considerations should be made to reduce the risk of adverse events when performing surgical procedures using a tissue graft. Please see the Instructions for Use (IFU) for more information on patient/product selection and surgical procedures involving tissue implantation before using ALLODERM SELECTTM RTM.

ADVERSE EVENTS

The most commonly reported adverse events associated with the implant of a tissue graft include, but are not limited to the following: wound or systemic infection; seroma; dehiscence; hypersensitive, allergic or other immune response; and sloughing or failure of the graft.

ALLODERM SELECTTM RTM is available by prescription only.

For more information, please see the Instructions for Use (IFU) for ALLODERM SELECTTM RTM available at www.allergan.com/AlloDermIFU or call 1.800.678.1605.

To report an adverse reaction, please call Allergan at 1.800.433.8871.

ALLODERM SELECTTM Regenerative Tissue Matrix Indications and  Important Safety Information 

ALLODERM SELECTTM Regenerative Tissue Matrix
Indications and Important Safety Information

INDICATIONS

ALLODERM SELECTTM Regenerative Tissue Matrix (ALLODERM SELECTTM RTM refers to both ALLODERM SELECTTM RTM and ALLODERM SELECT RESTORETM RTM products) is intended to be used for repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument. This product is intended for single patient one-time use only. ALLODERM SELECTTM RTM is not indicated for use as a dural substitute or intended for use in veterinary applications.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

ALLODERM SELECTTM RTM should not be used in patients with a known sensitivity to any of the antibiotics listed on the package and/or Polysorbate 20.

WARNINGS

Processing of the tissue, laboratory testing, and careful donor screening minimize the risk of the donor tissue transmitting disease to the recipient patient. As with any processed donor tissue, ALLODERM SELECTTM RTM is not guaranteed to be free of all pathogens. No long-term studies have been conducted to evaluate the carcinogenic or mutagenic potential or reproductive impact of the clinical application of ALLODERM SELECTTM RTM.

DO NOT re-sterilize ALLODERM SELECTTM RTM. DO NOT reuse once the tissue graft has been removed from the packaging and/or is in contact with a patient. Discard all open and unused portions of the product in accordance with standard medical practice and institutional protocols for disposal of human tissue. Once a package or container seal has been compromised, the tissue shall be either transplanted, if appropriate, or otherwise discarded. DO NOT use if the foil pouch is opened or damaged. DO NOT use if the seal is broken or compromised. DO NOT use if the temperature monitoring device does not display “OK.” DO NOT use after the expiration date noted on the label. Transfer ALLODERM SELECTTM RTM from the foil pouch aseptically. DO NOT place the foil pouch in the sterile field.

PRECAUTIONS

Poor general medical condition or any pathology that would limit the blood supply and compromise healing should be considered when selecting patients for implanting ALLODERM SELECTTM RTM as such conditions may compromise successful clinical outcome. Whenever clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic anti-infective measures should be taken.

ALLODERM SELECTTM RTM has a distinct basement membrane (upper) and dermal surface (lower). When applied as an implant, it is recommended that the dermal side be placed against the most vascular tissue. Soak the tissue for a minimum of 2 minutes using a sterile basin and room temperature sterile saline or room temperature sterile lactated Ringer’s solution to cover the tissue. If any hair is visible, remove using aseptic technique before implantation.

ALLODERM SELECTTM RTM should be hydrated and moist when the package is opened. DO NOT use if this product is dry. Use of this product is limited to specific health professionals (e.g., physicians, dentists, and/or podiatrists). Certain considerations should be made to reduce the risk of adverse events when performing surgical procedures using a tissue graft. Please see the Instructions for Use (IFU) for more information on patient/product selection and surgical procedures involving tissue implantation before using ALLODERM SELECTTM RTM.

ADVERSE EVENTS

The most commonly reported adverse events associated with the implant of a tissue graft include, but are not limited to the following: wound or systemic infection; seroma; dehiscence; hypersensitive, allergic or other immune response; and sloughing or failure of the graft.

ALLODERM SELECTTM RTM is available by prescription only.

For more information, please see the Instructions for Use (IFU) for ALLODERM SELECTTM RTM.

To report an adverse reaction, please call Allergan at 1.800.433.8871.